1 January 2023 false No description of principal activity Taxfiler 2023.12 07737587business:PrivateLimitedCompanyLtd2023-01-012023-12-31 077375872022-12-31 077375872023-01-012023-12-31 07737587business:AuditExempt-NoAccountantsReport2023-01-012023-12-31 07737587business:FilletedAccounts2023-01-012023-12-31 077375872023-12-31 07737587business:Director12023-01-012023-12-31 07737587business:Director22023-01-012023-12-31 07737587business:Director32023-01-012023-12-31 07737587business:Director42023-01-012023-12-31 07737587business:CompanySecretary12023-01-012023-12-31 07737587business:RegisteredOffice2023-01-012023-12-31 077375872022-12-31 07737587core:WithinOneYear2023-12-31 07737587core:WithinOneYear2022-12-31 07737587core:ShareCapitalcore:PreviouslyStatedAmount2023-12-31 07737587core:ShareCapitalcore:PreviouslyStatedAmount2022-12-31 07737587core:SharePremiumcore:PreviouslyStatedAmount2023-12-31 07737587core:SharePremiumcore:PreviouslyStatedAmount2022-12-31 07737587core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-12-31 07737587core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2022-12-31 07737587core:PreviouslyStatedAmount2023-12-31 07737587core:PreviouslyStatedAmount2022-12-31 07737587business:SmallEntities2023-01-012023-12-31 07737587countries:EnglandWales2023-01-012023-12-31 07737587core:PlantMachinery2023-01-012023-12-31 07737587core:Goodwill2022-12-31 07737587core:Goodwill2023-12-31 07737587core:PlantMachinery2022-12-31 07737587core:PlantMachinery2023-12-31 07737587business:OrdinaryShareClass12023-01-012023-12-31 07737587business:OrdinaryShareClass12022-01-012022-12-31 077375872022-01-012022-12-31 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 07737587 (England and Wales)
Sabal Health and Pharma Ltd Unaudited accounts for the year ended 31 December 2023
Sabal Health and Pharma Ltd Unaudited accounts Contents
Page
- 2 -
Sabal Health and Pharma Ltd Company Information for the year ended 31 December 2023
Directors
T W Goodey J R Heslin S R Williams S Williams
Secretary
Martin Roberts
Company Number
07737587 (England and Wales)
Registered Office
Spa House 69 Southend Road Hockley Essex SS5 4PZ England
- 3 -
Sabal Health and Pharma Ltd Statement of financial position as at 31 December 2023
2023 
2022 
Notes
£ 
£ 
Fixed assets
Tangible assets
4,255 
6,751 
Current assets
Inventories
325,563 
349,538 
Debtors
731,997 
847,848 
Cash at bank and in hand
453,936 
303,263 
1,511,496 
1,500,649 
Creditors: amounts falling due within one year
(922,360)
(926,823)
Net current assets
589,136 
573,826 
Net assets
593,391 
580,577 
Capital and reserves
Called up share capital
3,774 
3,774 
Share premium
(470,554)
(470,554)
Profit and loss account
1,060,171 
1,047,357 
Shareholders' funds
593,391 
580,577 
For the year ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 30 January 2024 and were signed on its behalf by
T W Goodey Director Company Registration No. 07737587
- 4 -
Sabal Health and Pharma Ltd Notes to the Accounts for the year ended 31 December 2023
1
Statutory information
Sabal Health and Pharma Ltd is a private company, limited by shares, registered in England and Wales, registration number 07737587. The registered office is Spa House, 69 Southend Road, Hockley, Essex, SS5 4PZ, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover represents net invoiced sales of goods, excluding value added tax.
Tangible fixed assets policy
Depreciation is provided at the following annual rates in order to write off each assets over its estimated useful life:
Plant & machinery
33% on Cost
Stocks
Stocks and are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.
Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rates of exchange ruling at the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
Hire Purchase & Leasing Commitments
Rentals paid under operating leases are charged to the profit and loss account on a straight line basis over the period of the lease.
- 5 -
Sabal Health and Pharma Ltd Notes to the Accounts for the year ended 31 December 2023
4
Intangible fixed assets
Goodwill 
£ 
Cost
At 1 January 2023
5,000 
At 31 December 2023
5,000 
Amortisation
At 1 January 2023
5,000 
At 31 December 2023
5,000 
Net book value
At 31 December 2023
- 
5
Tangible fixed assets
Plant & machinery 
£ 
Cost or valuation
At cost 
At 1 January 2023
18,530 
At 31 December 2023
18,530 
Depreciation
At 1 January 2023
11,779 
Charge for the year
2,496 
At 31 December 2023
14,275 
Net book value
At 31 December 2023
4,255 
At 31 December 2022
6,751 
6
Debtors
2023 
2022 
£ 
£ 
Amounts falling due within one year
Trade debtors
719,674 
827,246 
Accrued income and prepayments
10,198 
18,477 
Other debtors
2,125 
2,125 
731,997 
847,848 
7
Creditors: amounts falling due within one year
2023 
2022 
£ 
£ 
VAT
167,808 
166,977 
Trade creditors
589,193 
595,483 
Taxes and social security
38,253 
51,629 
Other creditors
50,000 
55,125 
Loans from directors
10,250 
44,875 
Accruals
66,856 
12,734 
922,360 
926,823 
- 6 -
Sabal Health and Pharma Ltd Notes to the Accounts for the year ended 31 December 2023
8
Share capital
2023 
2022 
£ 
£ 
Allotted, called up and fully paid:
3,774 Ordinary shares of £1 each
3,774 
3,774 
9
Loans to directors
At the balance sheet date the company owed Thomas Goodey £10,250 in respect of his directors loan account.
10
Average number of employees
During the year the average number of employees was 6 (2022: 6).
- 7 -